FDA inspection
Qilu Antibiotics Pharmaceutical Co., Ltd.: FDA inspection ending Apr 28, 2021
FDA inspection 1141559 · Voluntary Action Indicated (VAI) · Jinan
Key facts
| Inspection ID | 1141559 |
|---|---|
| Firm | Qilu Antibiotics Pharmaceutical Co. , Ltd. |
| FEI number | 3009831352 |
| Address | No 849, Licheng District |
| City | Jinan |
| Fiscal year | 2021 |
| Inspection end date | Apr 28, 2021 |
| Classification | Voluntary Action Indicated (VAI) |
| Project area | Generic Drug Evaluation |
| Product type | Drugs |
At a glance
- None Citations
- 1–9 Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data